Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study.
Filippini T, Tesauro M, Fiore M, Malagoli C, Consonni M, Violi F, Iacuzio L, Arcolin E, Oliveri Conti G, Cristaldi A, Zuccarello P, Zucchi E, Mazzini L, Pisano F, Gagliardi I, Patti F, Mandrioli J, Ferrante M, Vinceti M. Filippini T, et al. Among authors: zucchi e. Int J Environ Res Public Health. 2020 Apr 22;17(8):2882. doi: 10.3390/ijerph17082882. Int J Environ Res Public Health. 2020. PMID: 32331298 Free PMC article.
Riluzole and other prognostic factors in ALS: a population-based registry study in Italy.
Mandrioli J, Malerba SA, Beghi E, Fini N, Fasano A, Zucchi E, De Pasqua S, Guidi C, Terlizzi E, Sette E, Ravasio A, Casmiro M, Salvi F, Liguori R, Zinno L, Handouk Y, Rizzi R, Borghi A, Rinaldi R, Medici D, Santangelo M, Granieri E, Mussuto V, Aiello M, Ferro S, Vinceti M; ERRALS Group. Mandrioli J, et al. Among authors: zucchi e. J Neurol. 2018 Apr;265(4):817-827. doi: 10.1007/s00415-018-8778-y. Epub 2018 Feb 5. J Neurol. 2018. PMID: 29404735
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis.
Mandrioli J, Ferri L, Fasano A, Zucchi E, Fini N, Moglia C, Lunetta C, Marinou K, Ticozzi N, Drago Ferrante G, Scialo C, Sorarù G, Trojsi F, Conte A, Falzone YM, Tortelli R, Russo M, Sansone VA, Mora G, Silani V, Volanti P, Caponnetto C, Querin G, Monsurrò MR, Sabatelli M, Chiò A, Riva N, Logroscino G, Messina S, Calvo A. Mandrioli J, et al. Among authors: zucchi e. Eur J Neurol. 2018 Jun;25(6):861-868. doi: 10.1111/ene.13620. Epub 2018 Apr 15. Eur J Neurol. 2018. PMID: 29512869 Free article.
Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial).
Mandrioli J, D'Amico R, Zucchi E, Gessani A, Fini N, Fasano A, Caponnetto C, Chiò A, Dalla Bella E, Lunetta C, Mazzini L, Marinou K, Sorarù G, de Biasi S, Lo Tartaro D, Pinti M, Cossarizza A; RAP-ALS investigators group. Mandrioli J, et al. Among authors: zucchi e. Medicine (Baltimore). 2018 Jun;97(24):e11119. doi: 10.1097/MD.0000000000011119. Medicine (Baltimore). 2018. PMID: 29901635 Free PMC article. Clinical Trial.
Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS).
Mandrioli J, Crippa V, Cereda C, Bonetto V, Zucchi E, Gessani A, Ceroni M, Chio A, D'Amico R, Monsurrò MR, Riva N, Sabatelli M, Silani V, Simone IL, Sorarù G, Provenzani A, D'Agostino VG, Carra S, Poletti A. Mandrioli J, et al. Among authors: zucchi e. BMJ Open. 2019 May 30;9(5):e028486. doi: 10.1136/bmjopen-2018-028486. BMJ Open. 2019. PMID: 31152038 Free PMC article.
105 results